Arcadia Biosciences (RKDA) Misses Q4 EPS by 97c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.97). Revenue for the quarter came in at $900 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings